Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 626

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Open access
Flaig, Thomas W., Spiess, Philippe E., Agarwal, Neeraj, Bangs, Rick, Boorjian, Stephen A., Buyyounouski, Mark K., Chang, Sam, Downs, Tracy M., Efstathiou, Jason A., Friedlander, Terence, Greenberg, Richard E., Guru, Khurshid A., Guzzo, Thomas, Herr, Harry W., Hoffman-Censits, Jean, Hoimes, Christopher, Inman, Brant A., Jimbo, Masahito, Kader, A. Karim, Lele, Subodh M., Michalski, Jeff, Montgomery, Jeffrey S., Nandagopal, Lakshminarayanan, Pagliaro, Lance C., Pal, Sumanta K., Patterson, Anthony, Plimack, Elizabeth R., Pohar, Kamal S., Preston, Mark A., Sexton, Wade J., Siefker-Radtke, Arlene O., Tward, Jonathan, Wright, Jonathan L., Gurski, Lisa A., Johnson-Chilla, Alyse · 2020 · Journal of the National Comprehensive Cancer Network

Abstract

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder cancer, treatment of non–muscle-invasive urothelial bladder cancer, and treatment of metastatic urothelial bladder cancer because important updates have recently been made to these sections. Some important updates include recommendations for optimal treatment of non–muscle-invasive bladder cancer in the event of a bacillus Calmette-Guérin (BCG) shortage and details about biomarker testing for advanced or metastatic disease. The systemic therapy recommendations for second-line or subsequent therapies have also been revised. Treatment and management of muscle-invasive, nonmetastatic disease is covered in the complete version of the NCCN Guidelines for Bladder Cancer available at NCCN.org. Additional topics covered in the complete version include treatment of nonurothelial histologies and recommendations for nonbladder urinary tract cancers such as upper tract urothelial carcinoma, urothelial carcinoma of the prostate, and primary carcinoma of the urethra.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2020.0011

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 626

Metadata

Authors
Flaig, T. W., Spiess, P. E., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chang, S., Downs, T. M., Efstathiou, J. A., Friedlander, T., Greenberg, R. E., Guru, K. A., Guzzo, T., Herr, H. W., Hoffman-Censits, J., Hoimes, C., Inman, B. A., Jimbo, M., Kader, A. K., Lele, S. M., Michalski, J., Montgomery, J. S., Nandagopal, L., Pagliaro, L. C., Pal, S. K., Patterson, A., Plimack, E. R., Pohar, K. S., Preston, M. A., Sexton, W. J., Siefker-Radtke, A. O., Tward, J., Wright, J. L., Gurski, L. A., & Johnson-Chilla, A.
Venue
Journal of the National Comprehensive Cancer Network
Published
2020-03
Volume
18
Issue
3
Pages
329-354
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W4242669880
Cited by
626
References
77
FWCI
90.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. https://app.cochat.ai/papers/10.6004/jnccn.2020.0011
The paper
Flaig, T. W., Spiess, P. E., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chang, S., Downs, T. M., Efstathiou, J. A., Friedlander, T., Greenberg, R. E., Guru, K. A., Guzzo, T., Herr, H. W., Hoffman-Censits, J., Hoimes, C., Inman, B. A., Jimbo, M., Kader, A. K., . . . Johnson-Chilla, A. (2020). Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2020.0011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.